Dasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutations

Improved therapies are greatly needed for non-small cell lung cancer (NSCLC) that does not harbor targetable kinase mutations or translocations. We previously demonstrated that NSCLC cells that harbor kinase-inactivating BRAF mutations ((KI)BRAF) undergo senescence when treated with the multitargete...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Peng, Shaohua, Sen, Banibrata, Mazumdar, Tuhina, Byers, Lauren A., Diao, Lixia, Wang, Jing, Tong, Pan, Giri, Uma, Heymach, John V., Kadara, Humam N., Johnson, Faye M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4808018/
https://ncbi.nlm.nih.gov/pubmed/26623721
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia